BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36428616)

  • 1. Comparison of Surgical Resection and Percutaneous Ultrasonographic Guided Radiofrequency Ablation for Initial Recurrence of Hepatocellular Carcinoma in Early Stage following Curative Treatment.
    Ohama H; Hiraoka A; Tada F; Kato K; Fukunishi Y; Yanagihara E; Kato M; Saneto H; Izumoto H; Ueki H; Yoshino T; Kitahata S; Kawamura T; Kuroda T; Suga Y; Miyata H; Hirooka M; Abe M; Matsuura B; Ninomiya T; Hiasa Y
    Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Role of Albumin-Bilirubin Grade in Hepatocellular Carcinoma After Ultrasound-guided Percutaneous Radiofrequency Ablation: A Single-center Experience Over a Decade.
    Long H; Xie X; Huang G; Huang T; Xie X; Liu B
    Surg Laparosc Endosc Percutan Tech; 2022 Jun; 32(3):350-356. PubMed ID: 35297807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes of surgical resection versus radiofrequency ablation in very-early-stage hepatocellular carcinoma: a propensity score matching analysis.
    Li YC; Chen PH; Yeh JH; Hsiao P; Lo GH; Tan T; Cheng PN; Lin HY; Chen YS; Hsieh KC; Hsieh PM; Lin CW
    BMC Gastroenterol; 2021 Nov; 21(1):418. PubMed ID: 34749663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. When to Perform Surgical Resection or Radiofrequency Ablation for Early Hepatocellular Carcinoma?: A Nomogram-guided Treatment Strategy.
    Liu PH; Hsu CY; Lee YH; Hsia CY; Huang YH; Su CW; Chiou YY; Lin HC; Huo TI
    Medicine (Baltimore); 2015 Oct; 94(43):e1808. PubMed ID: 26512576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Usefulness of Surgical Resection Including the Complementary Use of Radiofrequency Ablation for Intermediate-Stage Hepatocellular Carcinoma.
    Ohama H; Hiraoka A; Tada F; Kato K; Fukunishi Y; Yanagihara E; Kato M; Saneto H; Izumoto H; Ueki H; Yoshino T; Kitahata S; Kawamura T; Kuroda T; Suga Y; Miyata H; Hanaoka J; Watanabe J; Ohtani H; Hirooka M; Abe M; Matsuura B; Ninomiya T; Hiasa Y
    Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgery versus radiofrequency ablation in patients with Child- Pugh class-A/single small (≤3 cm) hepatocellular carcinoma.
    Lee J; Jin YJ; Shin SK; Kwon JH; Kim SG; Suh YJ; Jeong Y; Yu JH; Lee JW; Kwon OS; Nahm SW; Kim YS
    Clin Mol Hepatol; 2022 Apr; 28(2):207-218. PubMed ID: 34814239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Albumin-bilirubin grade predicts the outcomes of liver resection versus radiofrequency ablation for very early/early stage of hepatocellular carcinoma.
    Chong CC; Chan AW; Wong J; Chu CM; Chan SL; Lee KF; Yu SC; To KF; Johnson P; Lai PB
    Surgeon; 2018 Jun; 16(3):163-170. PubMed ID: 28807570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical Resection Versus Radiofrequency Ablation for Single Hepatocellular Carcinoma ≤ 2  cm in a Propensity Score Model.
    Liu PH; Hsu CY; Hsia CY; Lee YH; Huang YH; Chiou YY; Lin HC; Huo TI
    Ann Surg; 2016 Mar; 263(3):538-45. PubMed ID: 25775062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimally invasive surgery versus percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma: Results from a high-volume liver surgery center in East Asia.
    Liu YW; Yen YH; Li WF; Wang CC; Lu SN; Kee KM; Yong CC; Cheng YF; Wang JH; Hu TH; Hung CH; Chen CH
    Surg Oncol; 2022 Jun; 42():101769. PubMed ID: 35468499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Overall Survival between Surgical Resection and Radiofrequency Ablation for Hepatitis B-Related Hepatocellular Carcinoma.
    Hur MH; Lee JH; Kim JY; Hong JH; Park MK; Cho HJ; Choi NR; Kim J; Kim MA; Nam JY; Lee YB; Cho EJ; Yu SJ; Kim YJ; Lee DH; Lee JM; Hong SK; Yi NJ; Lee KW; Suh KS; Yoon JH
    Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tenofovir vs. Entecavir on Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma after Radiofrequency Ablation.
    Hu Z; Zeng H; Hou J; Wang J; Xu L; Zhang Y; Chen M; Zhou Z
    Viruses; 2022 Mar; 14(4):. PubMed ID: 35458386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (≤ 5 cm) after initial curative resection.
    Feng Y; Wu H; Huang DQ; Xu C; Zheng H; Maeda M; Zhao X; Wang L; Xiao F; Lv H; Liu T; Qi J; Li J; Zhong N; Wang C; Feng H; Liang B; Ren W; Qin C; Nguyen MH; Zhu Q
    Eur Radiol; 2020 Nov; 30(11):6357-6368. PubMed ID: 32529568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Albumin-bilirubin grade may determine the outcomes of patients with very early stage hepatocellular carcinoma after radiofrequency ablation therapy.
    Chen PC; Chiu NC; Su CW; Huang YH; Hou MC; Lin HC; Wu JC
    J Chin Med Assoc; 2019 Jan; 82(1):2-10. PubMed ID: 30839396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of overall survival on surgical resection versus transarterial chemoembolization with or without radiofrequency ablation in intermediate stage hepatocellular carcinoma: a propensity score matching analysis.
    Lin CW; Chen YS; Lo GH; Hsu YC; Hsu CC; Wu TC; Yeh JH; Hsiao P; Hsieh PM; Lin HY; Shu CW; Hung CM
    BMC Gastroenterol; 2020 Apr; 20(1):99. PubMed ID: 32272898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical resection versus radiofrequency ablation very early-stage HCC (≤2 cm Single HCC): A propensity score analysis.
    Chu HH; Kim JH; Kim PN; Kim SY; Lim YS; Park SH; Ko HK; Lee SG
    Liver Int; 2019 Dec; 39(12):2397-2407. PubMed ID: 31549771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiofrequency ablation versus resection for the treatment of early stage hepatocellular carcinoma: a multicenter Australian study.
    Gory I; Fink M; Bell S; Gow P; Nicoll A; Knight V; Dev A; Rode A; Bailey M; Cheung W; Kemp W; Roberts SK;
    Scand J Gastroenterol; 2015 May; 50(5):567-76. PubMed ID: 25615260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No-touch multibipolar radiofrequency ablation vs. surgical resection for solitary hepatocellular carcinoma ranging from 2 to 5 cm.
    Mohkam K; Dumont PN; Manichon AF; Jouvet JC; Boussel L; Merle P; Ducerf C; Lesurtel M; Rode A; Mabrut JY
    J Hepatol; 2018 Jun; 68(6):1172-1180. PubMed ID: 29410287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical resection versus radiofrequency ablation for Barcelona Clinic Liver Cancer very early stage hepatocellular carcinoma: long-term results of a single-center study.
    Hsiao CY; Hu RH; Ho CM; Wu YM; Lee PH; Ho MC
    Am J Surg; 2020 Oct; 220(4):958-964. PubMed ID: 32247523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resection or ablation versus transarterial therapy for Child-Pugh A patients with a single small hepatocellular carcinoma.
    Suh YJ; Jin YJ; Jeong Y; Shin WY; Lee JM; Cho S; Yu JH; Lee JW
    Medicine (Baltimore); 2021 Oct; 100(43):e27470. PubMed ID: 34713824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and prognostic factors of repeated hepatectomy for postoperative intrahepatic recurrence of hepatocellular carcinoma undergoing initial hepatectomy.
    Cen F; Sun X; Pan Z; Yan Q
    Front Med (Lausanne); 2023; 10():1127122. PubMed ID: 37250648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.